Dallah Healthcare Company SJSC
SAU:4004
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (24.9), the stock would be worth ﷼408.57 (152% upside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 9.9 | ﷼162.2 |
0%
|
| 3-Year Average | 24.9 | ﷼408.57 |
+152%
|
| 5-Year Average | 16.6 | ﷼271.98 |
+68%
|
| Industry Average | 48.3 | ﷼791.39 |
+388%
|
| Country Average | 25.2 | ﷼413.29 |
+155%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| SA |
|
Dallah Healthcare Company SJSC
SAU:4004
|
16.4B SAR | 9.9 | 18.8 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
96.8B USD | 10.5 | 14.3 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 93.8 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.7B ZAR | 14.5 | 14.1 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.9B MYR | 34.4 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.7B ZAR | 9.5 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
84.7B BRL | 107.3 | 18.1 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.9B USD | 6.1 | 9.4 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
100.5B CNY | 24.1 | 29.8 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 43.2 | 60.8 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.7B USD | 29.2 | 30.7 |
Market Distribution
| Min | 1.2 |
| 30th Percentile | 16.8 |
| Median | 25.2 |
| 70th Percentile | 44.6 |
| Max | 11 988.3 |
Other Multiples
Dallah Healthcare Company SJSC
Glance View
In the bustling heart of Saudi Arabia, Dallah Healthcare Company SJSC stands as a beacon of medical excellence and innovation, weaving a rich tapestry of healthcare services that cater to a diverse population. Founded in 1987, the company grew from its flagship Dallah Hospital in Riyadh, a state-of-the-art institution designed to meet international healthcare standards. Over the years, Dallah has meticulously expanded its reach, both in geographical scope and range of services, establishing itself as a pioneer in the Saudi healthcare sector. Its facilities are equipped with cutting-edge technology and staffed by highly skilled medical professionals who provide a wide array of services, from basic outpatient care to complex surgeries and specialized treatments. Fundamentally, Dallah Healthcare's business model revolves around offering comprehensive healthcare services that generate revenue primarily through patient fees. The company also capitalizes on its strategic partnerships and collaborations with insurance companies, enhancing its customer base by ensuring healthcare accessibility to insured patients. Additionally, Dallah invests in ancillary services like pharmacies and diagnostic centers, creating a robust network that offers integrated care solutions. This diversified approach not only ensures a steady flow of income but also positions Dallah as a key player in fulfilling the Kingdom’s vision for a healthier future, aligning with broader national health initiatives while continually striving to provide high-quality medical services.